Nasdaq

Gain Therapeutics Appoints New CEO Amidst Clinical Progress

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Gain Therapeutics ( ...
ascopubs.org

Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies

Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies The following represents disclosure information ...
Nasdaq

Gain Therapeutics, Inc. Reports Q1 2025 Financial Results and Corporate Update, Highlights Progress in Parkinson’s Disease Drug Development

Gain Therapeutics reports Q1 2025 financial results, progressing Phase 1b study of Parkinson's treatment GT-02287, with FDA engagement anticipated. Successful administration of GT-02287, a lead drug ...

Can sudden weight gain or weight loss damage your kidneys? Know about renal function decline and risk factors

Sudden weight fluctuations significantly impact kidney health, increasing the risk of chronic kidney disease progression and reduced function. Both ra ...
Yahoo

Exercise Scientist Reveals 5 Common Bulking Mistakes Hurting Your Muscle Gains

Bulking season can be the most exciting time in a lifter’s journey—more food, heavier lifts, and the promise of muscle growth. But it’s also the time when many make mistakes that derail progress, ...